Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Welcome
Go
Free Newsletter Sign Up

Diversity Urged to Play Greater Role in Drug, Research Reviews

May 17, 2022, 7:12 PM

The ongoing lack of diversity in clinical trials will further exacerbate health disparities in the US unless the biomedical research enterprise makes systemic changes, a National Academies report released Tuesday found.

The report calls for changes in several health agencies to require that diversity considerations have more weight in the review of new drug and research grant applications. One of those recommendations for the Food and Drug Administration will be part of a House Energy and Commerce markup Wednesday.

The recommendations mark the latest effort to tackle a challenge that the biomedical ecosystem has faced for decades. Laws and federal ...